Cargando…
SARS‐CoV‐2 and hypertension
The objective of this review is to give an overview of the pathophysiological effects of the Coronavirus Disease 2019 (COVID‐19) in relation to hypertension (HT), with a focus on the Renin–Angiotensin–Aldosterone System (RAAS) and the MAS receptor. HT is a multifactorial disease and a public health...
Autores principales: | Ravichandran, Briyanth, Grimm, Daniela, Krüger, Marcus, Kopp, Sascha, Infanger, Manfred, Wehland, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198473/ https://www.ncbi.nlm.nih.gov/pubmed/34121359 http://dx.doi.org/10.14814/phy2.14800 |
Ejemplares similares
-
Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension
por: Milling, Rikke Vilsbøll, et al.
Publicado: (2018) -
The Vasoactive Mas Receptor in Essential Hypertension
por: Povlsen, Amalie L., et al.
Publicado: (2020) -
Kinase-Inhibitors in Iodine-Refractory Differentiated Thyroid Cancer—Focus on Occurrence, Mechanisms, and Management of Treatment-Related Hypertension
por: Kaae, Anne Christine, et al.
Publicado: (2021) -
Potential Beneficial Effects of Vitamin D in Coronary Artery Disease
por: Legarth, Christian, et al.
Publicado: (2019) -
The Effect of Continuous Positive Airway Pressure Therapy on Obstructive Sleep Apnea-Related Hypertension
por: Baran, Ronni, et al.
Publicado: (2021)